Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa

Background South Africa recently experienced a first peak in COVID-19 cases and mortality. Dexamethasone and remdesivir both have the potential to reduce COVID-related mortality, but their cost-effectiveness in a resource-limited setting with scant intensive care resources is unknown. Methods We pro...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:medRxiv
Autori principali: Jo, Youngji, Jamieson, Lise, Edoka, Ijeoma, Long, Lawrence, Silal, Sheetal, Pulliam, Juliet R.C., Moultrie, Harry, Sanne, Ian, Meyer-Rath, Gesine, Nichols, Brooke E
Natura: Artigo
Lingua:Inglês
Pubblicazione: Cold Spring Harbor Laboratory 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7523165/
https://ncbi.nlm.nih.gov/pubmed/32995824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.09.24.20200196
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi